ADI ALKA SYP
Each 5 ml Contains : Disodium Hydrogen Citrate BP 1.38 gm In Flavoured Palatable Base q.s
| Composition | Each 5 ml Contains : Disodium Hydrogen Citrate BP 1.38 gm In Flavoured Palatable Base q.s |
| Packing | PET BOTTLE WITH MEASURING CAP - 100 ML |
| MRP | ₹94 |
Product Overview
ADI ALKA SYP is a fast-acting urinary alkalinizer formulated to relieve painful, burning urination and prevent the formation of uric acid and kidney stones. By neutralizing excess acid in the urine, it provides soothing relief from lower urinary tract discomfort associated with urinary tract infections (UTIs). Its palatable flavored base ensures excellent patient compliance during acute urinary distress.
Indications
This syrup is primarily indicated for:
- Burning Micturition: Symptomatic relief from burning and pain during urination associated with urinary tract infections and cystitis.
- Renal Calculi: Prevention and treatment of uric acid and cystine kidney stones by promoting stone dissolution.
- Renal Tubular Acidosis: Adjunctive management of metabolic acidosis and gout to facilitate urinary excretion of uric acid.
- Adjuvant to Antibiotic Therapy: Enhancing the antibacterial activity of certain urinary anti-infectives (such as sulfonamides and aminoglycosides).
Dosage & Administration
Adults: 15 ml (3 teaspoonfuls) diluted in a glass of water, taken 2 to 3 times daily after meals. Children (6 to 12 years): 5 ml diluted in water, 2 to 3 times daily after meals, or as directed by a physician. Must always be diluted with adequate water before ingestion.
Adverse Effects
- Mild stomach cramps or abdominal discomfort
- Diarrhea or flatulence
- Nausea and vomiting if taken on an empty stomach
- Fluid retention or systemic alkalosis with excessive use
View Complete Medical Information
Contraindications
Contraindicated in patients with severe renal impairment, oliguria, anuria, untreated Addison's disease, severe myocardial damage, and severe hypertension. Do not use in patients with sodium-restricted diets or metabolic alkalosis.
Warnings & Precautions
Use with caution in patients with cardiac disease, hypertension, edema, or hypocalcemia. Frequent monitoring of serum electrolytes and urinary pH is recommended during prolonged therapy to prevent metabolic alkalosis.
Drug Interactions
Concurrent use with potassium-sparing diuretics, ACE inhibitors, or potassium supplements may increase the risk of hyperkalemia or electrolyte imbalance. Alkalinization of urine may increase the half-life and decrease the urinary excretion of basic drugs like quinidine and amphetamines, while increasing the excretion of acidic drugs like salicylates and tetracyclines.
Storage Instructions
Store below 30°C in a cool, dry place, protected from light. Ensure the bottle is tightly capped after every use. Do not refrigerate.
Request This Product
- WHO-GMP Certified Formulations
- Monopoly Rights Available
- Get bulk pricing & MOQ
+91 9689237122 · replies within hours
Related Products
More products in the NEPHRO therapeutic category
ALKA C SYP
Each 5 ml contains: Disodium Hydrogen Citrate BP 1.38 gm In Flavoured Palatable Base q.s.
PET BOTTLE WITH MEAS CAP - 100 ML
CRANDY SYRUP
Each 15 ml contains : cranberry extract 200 mg d-mannose 300 mg potassium magnesium citrate 978 mg
Amber brute bottle with outer carton - 150 ML
STONGORIC SYP
Each 5 ml contains:Varun chhal (Crataeva nurvala) 200 mg, Kulathi (Dolichos biflorus) 50 mg, Mooli beej (Raphanus sativus) 50 mg Pashanbhed (Saxifraga lingulata) 50 mg, Punarnava (Boerhavia diffusa) 50 mg, Gokshur (Tribulus terrestris) 50 mg Chopchini (Smilax china) 50 mg, Amalki (Emblica officinalis) 25 mg Sugar (Saccharum officinarum)
PET BOTTLE - 200 ML
Interested in this product?
Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.